Detalhe da pesquisa
1.
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.
Am J Drug Alcohol Abuse
; 49(5): 618-629, 2023 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791817
2.
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.
Am J Addict
; 30(5): 470-476, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223681
3.
Open-label pilot study of lisdexamfetamine for cocaine use disorder.
Am J Drug Alcohol Abuse
; 47(3): 402-409, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797985
4.
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.
Am J Drug Alcohol Abuse
; 47(4): 467-475, 2021 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092158
5.
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.
Am J Addict
; 29(4): 345-348, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167629
6.
Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.
Am J Drug Alcohol Abuse
; 46(1): 44-48, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31339797
7.
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.
Am J Addict
; 27(2): 101-107, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29457671
8.
Open-label pilot study of injectable naltrexone for cannabis dependence.
Am J Drug Alcohol Abuse
; 44(6): 619-627, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420073
9.
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence.
Am J Addict
; 25(8): 666-672, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28051838
10.
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.
Drug Alcohol Depend
; 219: 108482, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418204
11.
Quetiapine treatment for cannabis use disorder.
Drug Alcohol Depend
; 218: 108366, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33153828
12.
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.
J Atten Disord
; 24(11): 1487-1492, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27033880
13.
Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users.
Drug Alcohol Depend
; 206: 107700, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753736
14.
How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.
Drug Alcohol Depend
; 188: 135-140, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29775957
15.
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Drug Alcohol Depend
; 159: 53-60, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711160
16.
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
JAMA Psychiatry
; 72(6): 593-602, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887096
17.
The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.
J Clin Psychiatry
; 73(11): e1372-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23218166